Related Experiment Video
Updated: Aug 24, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003
David J Farrell1, David Felmingham
1GR Micro Limited, London, United Kingdom. D.Farrell@grmicro.co.uk
Abstract:
Telithromycin MICs for 13,874 Streptococcus pneumoniae isolates collected in the first 3 years of the global PROTEKT study (1999 to 2003) were studied. There was no change in the distribution of telithromycin MICs over this period, even in countries where telithromycin is in use. The telithromycin MICs for 10 isolates (0.07%) were >/=4 micro g/ml, and these 10 isolates contained erm(B); there was no evidence of reproducible clonal spread between centers.
Related Concept Videos
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
